Hepatopulmonary Syndrome: Clinical Observations and Lack of Therapeutic Response To Somatostatin Analogue

We retrospectively studied 22 patients with hepatopulmonary syndrome (HPS) evaluated at the Mayo Medical Center from 1984 to 1991. All patients had hepatic cirrhosis with clinical evidence of portal hypertension; 13 (59 percent) had severe hypoxemia while breathing room air in the supine position (PaO2 < 60 mm Hg), and 14 of 16 (88 percent) had orthodeoxia breathing room air. On the basis of angiographic observations, we defined type 1 and type 2 patterns of pulmonary vascular abnormalities in HPS. Response to 100 percent oxygen and therapeutic regimens may differ in the angiographic patterns. Substantial deterioration in PaO2 associated with clinically stable hepatic dysfunction was documented in five of seven patients studied with sequential arterial blood gas testing; four subsequently died within 48 months. Overall mortality was 41 percent, occurring a mean of 2.5 years after diagnosis. In 7 of the 22 patients, we prospectively studied the effect of somatostatin analogue given subcutaneously for 4 consecutive days. No significant improvement in PaO2 was documented while breathing room air or 100 percent oxygen (p < 0.05). We conclude that in selected patients with clinically stable hepatic dysfunction and deteriorating oxygenation, the prognosis is poor. Our data in combination with recent surgical reports suggest that liver transplantation may be the treatment of choice in patients with HPS and worsening oxygenation.

[1]  D. V. van Thiel,et al.  Liver transplantation following preoperative closure of intrapulmonary shunts. , 1994, The Journal of the Oklahoma State Medical Association.

[2]  P. Lebecque,et al.  REVERSAL OF CIRRHOSIS‐RELATED PULMONARY SHUNTING IN TWO CHILDREN BY ORTHOTOPIC LIVER TRANSPLANTATION , 1992, Transplantation.

[3]  P. Batra,et al.  Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. , 1991, The American journal of medicine.

[4]  G. Hedenstierna,et al.  Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. , 1991, The European respiratory journal.

[5]  J. Roca,et al.  The lung in patients with cirrhosis. , 1990, Journal of hepatology.

[6]  D. Moodie,et al.  Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation , 1990, Hepatology.

[7]  D. Cortese,et al.  Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation , 1990, Hepatology.

[8]  N. Shah,et al.  Cirrhosis of liver simulating congenital cyanotic heart disease. , 1989, Circulation.

[9]  D. Cortese,et al.  Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. , 1987, Mayo Clinic proceedings.

[10]  H. Anderson,et al.  Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. , 1983, The American review of respiratory disease.

[11]  M. Brachman,et al.  Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. , 1977, American Journal of Medicine.

[12]  T. Kennedy,et al.  Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. , 1977, Chest.

[13]  J. Seward,et al.  Detecting intrapulmonary right-to-left shunt with contrast echocardiography. Observations in a patient with diffuse pulmonary arteriovenous fistulas. , 1976, Mayo Clinic proceedings.

[14]  R. Sapru,et al.  Cirrhosis, cyanosis and polycythaemia: multiple pulmonary arteriovenous anastomoses. , 1968, The American journal of medicine.

[15]  N. Shah,et al.  Cirrhosis of Liver Simulating Congenital Cyanotic Heart Disease , 1966, Chest.

[16]  F. W. Hoffbauer,et al.  Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. , 1956, The American journal of medicine.

[17]  P. Enright,et al.  Carbon monoxide diffusing capacity of the lungs determined by single-breath and steady-state exercise methods. , 1989, Mayo Clinic proceedings.

[18]  E. Robin,et al.  Detection, quantitation and pathophysiology of lung "spiders". , 1975, Transactions of the Association of American Physicians.